| Serial Number | 88048354 |
| Word Mark | CYTOSEN |
| Filing Date | Monday, July 23, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, July 6, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 9, 2019 |
| Goods and Services | Pharmaceutical preparations for the treatment of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use; biological preparations for the treatment of cancer; therapeutic pharmaceuticals utilizing neural crest cells for use in the treatment of cancer, autoimmune disease and infectious diseases; Cell preparations, cellular vaccines and cellular biologics for the treatment of cancer and infectious diseases by autologous cell-based immunotherapy |
| Goods and Services | Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies using natural killer cells; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable natural killer cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; Conducting research and clinical trials for others relating to the use and the engineering of natural killer cells and cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data; collection and preservation of human and animal DNA for research purposes |
| Goods and Services | Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing services; collection and preservation of dna for medical purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare and cancer diagnoses; providing a website featuring health and healthcare information related to cancer, testing and screening; genetic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; providing genetics assessments in the nature of genetic counseling; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes; Gene analysis and sequencing and DNA analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes; gene analysis and sequencing and DNA analysis and sequencing for use in cancer diagnosis and treatment; providing a website featuring health and healthcare information related to cancer research |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 26, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 26, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 26, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | KIADIS PHARMA INTELLECTUAL PROPERTY B.V. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | AMSTERDAM 1105 BP NL |
| Party Name | CytoSen Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Winter Springs, FL 32708 |
| Party Name | CytoSen Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Winter Springs, FL 32708 |
| Event Date | Event Description |
| Wednesday, December 23, 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, July 6, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, July 6, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, December 6, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 4, 2019 | EXTENSION 1 GRANTED |
| Wednesday, December 4, 2019 | EXTENSION 1 FILED |
| Wednesday, December 4, 2019 | TEAS EXTENSION RECEIVED |
| Tuesday, June 4, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 9, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 9, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 20, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 5, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 5, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, March 5, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 5, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 5, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 4, 2019 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, February 26, 2019 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, February 14, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, February 11, 2019 | ASSIGNED TO LIE |
| Monday, January 28, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 23, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 22, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 22, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 20, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 20, 2018 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 20, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, November 8, 2018 | ASSIGNED TO EXAMINER |
| Thursday, July 26, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, July 26, 2018 | NEW APPLICATION ENTERED IN TRAM |